← Mechanisms of action
KDR
SINGLE PROTEINHomo sapiens
Preferred name: Vascular endothelial growth factor receptor 2 ChEMBL ↗
Linked proteins
Drugs acting on this target (67)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| bpc-157 | Activator | experimental | Peptide | KDR activator |
| alacizumab pegol | Antagonist | experimental | mAb | KDR antagonist |
| kdr2-2 | Antagonist | experimental | Small molecule | KDR antagonist |
| ranibizumab (lucentis) | Antagonist | approved | mAb | KDR antagonist |
| st-1898 | Antagonist | experimental | Small molecule | KDR antagonist |
| br55 | Binding agent | experimental | Small molecule | KDR binding agent |
| vegfr2 | Immunity, active | experimental | Vaccine | KDR immunity, active |
| vegfr2-169 | Immunity, active | experimental | Vaccine | KDR immunity, active |
| vxm01 | Immunity, active | experimental | Biological | KDR immunity, active |
| anti-vegfr2 car cd8 t cells | Immunity, passive | experimental | Cell therapy | KDR immunity, passive |
| Acrizanib | Inhibitor | experimental | Small molecule | KDR inhibitor |
| aee-788 | Inhibitor | experimental | Small molecule | KDR inhibitor |
| ak109 | Inhibitor | experimental | mAb | KDR inhibitor |
| alacizumab pegol | Inhibitor | experimental | mAb | KDR inhibitor |
| altiratinib | Inhibitor | experimental | Small molecule | KDR inhibitor |
| anlotinib | Inhibitor | experimental | Small molecule | KDR inhibitor |
| anrotenib | Inhibitor | experimental | Small molecule | KDR inhibitor |
| axt107 | Inhibitor | experimental | Small molecule | KDR inhibitor |
| bc001 | Inhibitor | experimental | mAb | KDR inhibitor |
| bfh772 | Inhibitor | experimental | Small molecule | KDR inhibitor |
| bms-794833 | Inhibitor | experimental | Small molecule | KDR inhibitor |
| bms-817378 | Inhibitor | experimental | Small molecule | KDR inhibitor |
| bms-844203 | Inhibitor | experimental | Recombinant protein | KDR inhibitor |
| brivanab | Inhibitor | experimental | Small molecule | KDR inhibitor |
| cabozantinib (cometriq) | Inhibitor | approved | Small molecule | KDR inhibitor |
| cgi-1842 | Inhibitor | experimental | Small molecule | KDR inhibitor |
| chir-265 | Inhibitor | experimental | Small molecule | KDR inhibitor |
| cm-082 | Inhibitor | experimental | Small molecule | KDR inhibitor |
| cp-547632 | Inhibitor | experimental | Small molecule | KDR inhibitor |
| cyc116 | Inhibitor | experimental | Small molecule | KDR inhibitor |
| enmd 2076 | Inhibitor | experimental | Small molecule | KDR inhibitor |
| esk981 | Inhibitor | experimental | Small molecule | KDR inhibitor |
| etn101 | Inhibitor | experimental | Small molecule | KDR inhibitor |
| eyp-1901 | Inhibitor | experimental | Small molecule | KDR inhibitor |
| famitinib | Inhibitor | experimental | Small molecule | KDR inhibitor |
| fn-1501 | Inhibitor | experimental | Small molecule | KDR inhibitor |
| genakumab | Inhibitor | experimental | mAb | KDR inhibitor |
| gentuximab | Inhibitor | experimental | mAb | KDR inhibitor |
| golvatinib | Inhibitor | experimental | Small molecule | KDR inhibitor |
| henatinib | Inhibitor | experimental | Small molecule | KDR inhibitor |
| hlx06 | Inhibitor | experimental | mAb | KDR inhibitor |
| imc-1c11 | Inhibitor | experimental | mAb | KDR inhibitor |
| jdb153 | Inhibitor | experimental | Small molecule | KDR inhibitor |
| kanitinib | Inhibitor | experimental | Small molecule | KDR inhibitor |
| kc1036 | Inhibitor | experimental | Small molecule | KDR inhibitor |
| kh903 | Inhibitor | experimental | mAb | KDR inhibitor |
| lapatinib (tykerb) | Inhibitor | approved | Small molecule | KDR inhibitor |
| metatinib | Inhibitor | experimental | Small molecule | KDR inhibitor |
| midostaurin (rydapt) | Inhibitor | approved | Small molecule | KDR inhibitor |
| msb0254 | Inhibitor | experimental | mAb | KDR inhibitor |
| ningetinib | Inhibitor | experimental | Small molecule | Vascular endothelial growth factor receptor 2 inhibitor |
| orantinib | Inhibitor | experimental | Small molecule | KDR inhibitor |
| pf00337210 | Inhibitor | experimental | Small molecule | KDR inhibitor |
| puquitinib | Inhibitor | experimental | Small molecule | KDR inhibitor |
| ramucirumab (cyramza) | Inhibitor | approved | mAb | KDR inhibitor |
| simmitinib | Inhibitor | experimental | Small molecule | KDR inhibitor |
| sunitinib (sutent) | Inhibitor | approved | Small molecule | Vascular endothelial growth factor receptor 2 inhibitor |
| surufatinib | Inhibitor | experimental | Small molecule | KDR inhibitor |
| syha1813 | Inhibitor | experimental | Small molecule | KDR inhibitor |
| tanibirumab | Inhibitor | experimental | mAb | Vascular endothelial growth factor receptor 2 inhibitor |
| tas-115 | Inhibitor | experimental | Small molecule | KDR inhibitor |
| tavo412 | Inhibitor | experimental | Small molecule | KDR inhibitor |
| telatinib | Inhibitor | experimental | Small molecule | KDR inhibitor |
| telatinib mesylate | Inhibitor | experimental | Small molecule | KDR inhibitor |
| tg-100801 | Inhibitor | experimental | Small molecule | KDR inhibitor |
| xl092 | Inhibitor | experimental | Small molecule | KDR inhibitor |
| zd4190 | Inhibitor | experimental | Small molecule | KDR inhibitor |